Phages for Human Applications Group Europe ASBL
Phages for Human Applications Group Europe reported total assets of 4,488 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Mar 2026).
The score of Phages for Human Applications Group Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -43 % Total assets -43 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Phages for Human Applications Group Europe's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Mar 2026
- Year ended 31 Dec 2023filed on 22 Apr 2024
- Year ended 31 Dec 2022filed on 28 Apr 2023
- Year ended 31 Dec 2021filed on 28 Mar 2022
- Year ended 31 Dec 2020filed on 31 Aug 2021
Phages for Human Applications Group Europe's financial analysis
Management and control of Phages for Human Applications Group Europe
7 active director(s) in the register.
and 1 more
Phages for Human Applications Group Europe's shareholders and holdings →Phages for Human Applications Group Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0817.142.747
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- ASBL
- Incorporated
- 15 Jul 2009
- Registered office
- 1120 Brussels
- Latest accounts
- 2025 · filed on 23 Mar 2026
Phages for Human Applications Group Europe (ASBL) has been based in Brussels since 2009, active in: —. For 2025, it reports a net loss of 740 € and equity of 4,488 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Phages for Human Applications Group Europe
Companies in the same business, of comparable size and area, outside its group.
- Ballucinant Berchem-Sainte-Agathe · balance sheet 4,505 €
- Zomergronds Leopoldsburg · balance sheet 4,402 €
- Carpe Diem Nijlen · balance sheet 4,595 €
- In Context Leuven · balance sheet 4,382 €
- Elite Athletes VZW Antwerp · balance sheet 4,373 €
- Association of European Data Protection Judges Woluwe-Saint-Lambert · balance sheet 4,348 €
- De Kloe vzw Antwerp · balance sheet 4,662 €
- Turritopsis Molenbeek-Saint-Jean · balance sheet 4,308 €
Frequently asked questions about Phages for Human Applications Group Europe
What is the revenue of Phages for Human Applications Group Europe?
Phages for Human Applications Group Europe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Phages for Human Applications Group Europe?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Phages for Human Applications Group Europe. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0817142747. Its company number (CBE) is 0817.142.747.
Where is the registered office of Phages for Human Applications Group Europe?
According to the CBE register, the registered office of Phages for Human Applications Group Europe is in 1120 Brussels.
What is the equity of Phages for Human Applications Group Europe?
At the close of the 2025 financial year, the equity of Phages for Human Applications Group Europe amounts to 4,488 €, a solvency of 100.0% of total assets.
Who manages Phages for Human Applications Group Europe?
The register lists 7 active mandates at Phages for Human Applications Group Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Phages for Human Applications Group Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →